ADHD trials recruiting in Florida

All ADHD trials nationally

Cities in Florida

Recruiting trials in Florida

• A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
  NCT07755410 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Florida: Maitland
• A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
  NCT07759154 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Florida: Gainesville, Jacksonville, Maitland
• An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms
  NCT07329673 · Phase: Not specified · Ages: 6 Years to 60 Years · Sex: All (male and female) · Florida: Miami
• Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
  NCT03781752 · Phase: Phase 4 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Florida: Gainesville
• Central Executive Training and Parent Training for ADHD
  NCT05492422 · Phase: Not applicable (e.g. observational or device study) · Ages: 8 Years to 12 Years · Sex: All (male and female) · Florida: Tallahassee
• Digital Dyadic Family Based Intervention to Improve Sleep in Children with ODD and Their Parents: NiteCAPP SINCC (Pilot)
  NCT06410495 · Phase: Not applicable (e.g. observational or device study) · Ages: 8 Years to 17 Years · Sex: All (male and female) · Florida: Tampa
• Evaluating the Efficacy of Central Executive Training (CET) For Young Children With ADHD
  NCT07784348 · Phase: Not applicable (e.g. observational or device study) · Ages: 4 Years to 8 Years · Sex: All (male and female) · Florida: Tallahassee
• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
  NCT04781140 · Phase: Phase 4 · Ages: 48 Months to 69 Months · Sex: All (male and female) · Florida: Coral Gables, Gainesville, Jacksonville, Miami
• Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
  NCT07717879 · Phase: Phase 3 · Ages: 6 Years to 11 Years · Sex: All (male and female) · Florida: Coral Gables, Jacksonville, Maitland, Orlando
• Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
  NCT07717892 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Florida: Coral Gables, Gainesville, Jacksonville, Maitland
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
  NCT04278404 · Phase: Not specified · Ages: 0 Years to 20 Years · Sex: All (male and female) · Florida: Jacksonville
• SLEEP-COPE: Sleep Intervention for Oppositional Children
  NCT06350292 · Phase: Not applicable (e.g. observational or device study) · Ages: 8 Years to 12 Years · Sex: All (male and female) · Florida: Tampa